PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MRSN vs. SGMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MRSN and SGMO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

MRSN vs. SGMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mersana Therapeutics, Inc. (MRSN) and Sangamo Therapeutics, Inc. (SGMO). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%500.00%JulyAugustSeptemberOctoberNovemberDecember
-24.85%
455.60%
MRSN
SGMO

Key characteristics

Sharpe Ratio

MRSN:

-0.16

SGMO:

3.72

Sortino Ratio

MRSN:

0.48

SGMO:

3.80

Omega Ratio

MRSN:

1.06

SGMO:

1.44

Calmar Ratio

MRSN:

-0.17

SGMO:

5.85

Martin Ratio

MRSN:

-0.30

SGMO:

13.32

Ulcer Index

MRSN:

54.21%

SGMO:

43.63%

Daily Std Dev

MRSN:

99.59%

SGMO:

156.21%

Max Drawdown

MRSN:

-96.16%

SGMO:

-99.40%

Current Drawdown

MRSN:

-94.20%

SGMO:

-95.02%

Fundamentals

Market Cap

MRSN:

$255.71M

SGMO:

$563.24M

EPS

MRSN:

-$0.60

SGMO:

-$1.24

PEG Ratio

MRSN:

0.00

SGMO:

0.00

Total Revenue (TTM)

MRSN:

$34.84M

SGMO:

$52.29M

Gross Profit (TTM)

MRSN:

$16.72M

SGMO:

$44.21M

EBITDA (TTM)

MRSN:

-$68.51M

SGMO:

-$125.31M

Returns By Period

In the year-to-date period, MRSN achieves a -31.03% return, which is significantly lower than SGMO's 354.45% return.


MRSN

YTD

-31.03%

1M

-27.93%

6M

-24.88%

1Y

-17.53%

5Y*

-19.35%

10Y*

N/A

SGMO

YTD

354.45%

1M

25.97%

6M

448.06%

1Y

581.29%

5Y*

-21.78%

10Y*

-16.80%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MRSN vs. SGMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mersana Therapeutics, Inc. (MRSN) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MRSN, currently valued at -0.16, compared to the broader market-4.00-2.000.002.00-0.163.72
The chart of Sortino ratio for MRSN, currently valued at 0.48, compared to the broader market-4.00-2.000.002.004.000.483.80
The chart of Omega ratio for MRSN, currently valued at 1.06, compared to the broader market0.501.001.502.001.061.44
The chart of Calmar ratio for MRSN, currently valued at -0.17, compared to the broader market0.002.004.006.00-0.175.88
The chart of Martin ratio for MRSN, currently valued at -0.30, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.3013.32
MRSN
SGMO

The current MRSN Sharpe Ratio is -0.16, which is lower than the SGMO Sharpe Ratio of 3.72. The chart below compares the historical Sharpe Ratios of MRSN and SGMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
-0.16
3.72
MRSN
SGMO

Dividends

MRSN vs. SGMO - Dividend Comparison

Neither MRSN nor SGMO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MRSN vs. SGMO - Drawdown Comparison

The maximum MRSN drawdown since its inception was -96.16%, roughly equal to the maximum SGMO drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for MRSN and SGMO. For additional features, visit the drawdowns tool.


-98.00%-96.00%-94.00%-92.00%-90.00%JulyAugustSeptemberOctoberNovemberDecember
-94.20%
-90.63%
MRSN
SGMO

Volatility

MRSN vs. SGMO - Volatility Comparison

The current volatility for Mersana Therapeutics, Inc. (MRSN) is 33.45%, while Sangamo Therapeutics, Inc. (SGMO) has a volatility of 39.68%. This indicates that MRSN experiences smaller price fluctuations and is considered to be less risky than SGMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%JulyAugustSeptemberOctoberNovemberDecember
33.45%
39.68%
MRSN
SGMO

Financials

MRSN vs. SGMO - Financials Comparison

This section allows you to compare key financial metrics between Mersana Therapeutics, Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab